HAS2 and glioblastoma: In GBM cells, however, exogenous addition of recombinant human C5a protein (rh-C5a) did not enhance HAS2 levels, implicating that GBM cells are intrinsically different from tMSLCS in terms of responsiveness to C5a (Figure 3H).